Pritam N. Dube
Pritam N. Dube publishes mostly in Organic Chemistry, Computational Theory and Mathematics and Molecular Biology, on topics such as Synthesis and biological activity, Computational Drug Discovery Methods and Estrogen and related hormone effects.
- World rank
- #7,276,724 of 7,710,434 ranked researchers
- Rank in India
- #258,360 of 280,097
- Works
- 26
- Citations
- 166
- Citations per work
- 6.4
What does Pritam N. Dube research?
Pritam N. Dube's work is mostly in Chemistry (47%), Biochemistry, Genetics and Molecular Biology (15%), Computer Science (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences1556.0%
- Chemistry1246.7%
- Computer Science29.3%
- Everything else624.0%
- Life Sciences414.7%
- Health Sciences15.3%
- Medicine15.3%
- 1Organic Chemistry43% of their works
- 2Computational Theory and Mathematics9% of their works
- 3Molecular Biology8% of their works
- 4Genetics7% of their works
- 5Pharmacology5% of their works
- 6Analytical Chemistry4% of their works
Research topics
- Synthesis and biological activity
- Computational Drug Discovery Methods
- Estrogen and related hormone effects
- Synthesis and Characterization of Heterocyclic Compounds
- Analytical Methods in Pharmaceuticals
- Synthesis and Biological Evaluation
- Click Chemistry and Applications
- Quinazolinone synthesis and applications
Which keywords describe Pritam N. Dube's research?
The keywords of their largest research topics: Medicinal Chemistry, Anticancer Agents, Heterocyclic Compounds, Tubulin Inhibitors, Vascular Targeting Agents, Molecular Docking, Biological Evaluation and Synthesis.
- Quinoxaline
- Pharmaceutical Analysis
- Green Analytical Chemistry
- Click Chemistry
- Triazines
- Receptor
- Virtual Screening
- Antimicrobial
- Synthesis
- Molecular Docking
- Tubulin Inhibitors
- Anticancer Agents
- Medicinal Chemistry
- Heterocyclic Compounds
- Vascular Targeting Agents
- Biological Evaluation
- Anticancer
- Drug Target Identification
- Estrogen
- Scaffold
- Antimicrobial Activity
- Copper-Catalyzed Cycloaddition
- Indirubin
- Quinazoline
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Medicinal Chemistry253 topics
- Anticancer Agents182 topics
- Heterocyclic Compounds182 topics
- Tubulin Inhibitors151 topic
- Vascular Targeting Agents151 topic
- Molecular Docking122 topics
- Biological Evaluation113 topics
- Synthesis113 topics
- Anticancer82 topics
- Antimicrobial82 topics
- Drug Target Identification71 topic
- Virtual Screening71 topic
- Estrogen51 topic
- Receptor51 topic
- Scaffold51 topic
- Triazines51 topic
- Antimicrobial Activity31 topic
- Click Chemistry31 topic
- Copper-Catalyzed Cycloaddition31 topic
- Green Analytical Chemistry31 topic
- Indirubin31 topic
- Pharmaceutical Analysis31 topic
- Quinazoline31 topic
- Quinoxaline31 topic
Where does Pritam N. Dube work?
Pritam N. Dube's main affiliation in the publication record is Sandip Foundation, India.
How many publications and citations does Pritam N. Dube have?
OpenAlex counts 26 works and 166 citations for Pritam N. Dube, an h-index of 8, ranking #7,276,724 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Pritam N. Dube. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.